Your browser doesn't support javascript.
loading
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Baroncini, Damiano; Zaffaroni, Mauro; Moiola, Lucia; Lorefice, Lorena; Fenu, Giuseppe; Iaffaldano, Pietro; Simone, Marta; Fanelli, Fulvia; Patti, Francesco; D'Amico, Emanuele; Capobianco, Marco; Bertolotto, Antonio; Gallo, Paolo; Margoni, Monica; Miante, Silvia; Milani, Nicoletta; Amato, Maria Pia; Righini, Isabella; Bellantonio, Paolo; Scandellari, Cinzia; Costantino, Gianfranco; Scarpini, Elio; Bergamaschi, Roberto; Mallucci, Giulia; Comi, Giancarlo; Ghezzi, Angelo.
Afiliação
  • Baroncini D; Multiple Sclerosis Study Center, Gallarate Hospital, ASST Valle Olona, Via Eusebio Pastori 4, 21013 Gallarate, Italy.
  • Zaffaroni M; Multiple Sclerosis Study Center, Gallarate Hospital, ASST Valle Olona, Via Eusebio Pastori 4, 21013 Gallarate, Italy.
  • Moiola L; Department of Neurology, San Raffaele Hospital, Milan, Italy.
  • Lorefice L; Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, Cagliari, Italy/Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Fenu G; Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, Cagliari, Italy/Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Iaffaldano P; Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Simone M; Child and Adolescence Neuropsychiatry Unit, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Fanelli F; Centro Sclerosi Multipla, Azienda Ospedaliera Sant Andrea, Università degli studi di Roma La Sapienza, Rome, Italy.
  • Patti F; Centro Sclerosi Multipla, Azienda Ospedaliera Sant Andrea, Università degli studi di Roma La Sapienza,Rome, Italy/Department of Medical and Surgical Science and Advanced Technologies, GF Ingrassia, Neurosciences Section, Multiple Sclerosis Center, University of Catania, Catania, Italy.
  • D'Amico E; Centro Sclerosi Multipla, Azienda Ospedaliera Sant Andrea, Università degli studi di Roma La Sapienza,Rome, Italy/Department of Medical and Surgical Science and Advanced Technologies, GF Ingrassia, Neurosciences Section, Multiple Sclerosis Center, University of Catania, Catania, Italy.
  • Capobianco M; Neurologia & CRESM (Centro Riferimento Regionale SM), AOU San Luigi, Orbassano, Italy.
  • Bertolotto A; Neurologia & CRESM (Centro Riferimento Regionale SM), AOU San Luigi, Orbassano, Italy.
  • Gallo P; Multiple Sclerosis Centre, Department of Neurosciences DNS, University Hospital, University of Padua, Padua, Italy.
  • Margoni M; Multiple Sclerosis Centre, Department of Neurosciences DNS, University Hospital, University of Padua, Padua, Italy.
  • Miante S; Multiple Sclerosis Centre, Department of Neurosciences DNS, University Hospital, University of Padua, Padua, Italy.
  • Milani N; Child Neuropsychiatry Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Amato MP; Department NEUROFARBA, University of Florence, Florence, Italy.
  • Righini I; Department NEUROFARBA, University of Florence, Florence, Italy.
  • Bellantonio P; Multiple Sclerosis Center, IRCCS Neuromed, Isernia, Italy.
  • Scandellari C; UOSD Riabilitazione e Sclerosi Multipla, Villa Mazzacorati, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Costantino G; Simple Unit Multiple Sclerosis, University Hospital of Ospedali Riuniti, Foggia, Italy.
  • Scarpini E; Multiple Sclerosis Center "Dino Ferrari," University of Milan IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
  • Bergamaschi R; Department of Neurology, Neurological Institute C. Mondino, Pavia, Italy.
  • Mallucci G; Department of Neurology, Neurological Institute C. Mondino, Pavia, Italy.
  • Comi G; Department of Neurology, San Raffaele Hospital, Milan, Italy/Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Hospital, Milan, Italy/.
  • Ghezzi A; Multiple Sclerosis Study Center, Gallarate Hospital, ASST Valle Olona, Via Eusebio Pastori 4, 21013 Gallarate, Italy.
Mult Scler ; 25(3): 399-407, 2019 03.
Article em En | MEDLINE | ID: mdl-29363396

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Progressão da Doença / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Progressão da Doença / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article